Jakob Siedlecki

23PUBLICATIONS
18CO-AUTHORS
Photonics, optoelectronics and optical communicationsAdditive manufacturingOptical technologyMedical molecular engineering of nucleic acids and proteinsVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 27, 2026
Mechanisms of Gas-Induced Posterior Vitreous Detachment: A Look Behind the Bubble Using Optical Coherence Tomography in Prone Position.

Julian Elias Klaas, Jakob Siedlecki, Benedikt Schworm

|Dec 15, 2025
Efficacy of 2 mg vs. High-Dose 8 mg Aflibercept in Neovascular Age Related Macular Degeneration.

Caspar Liesenhoff, Daniel Krause, Franziska Eckardt

|Nov 27, 2025
High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent?

Caspar Liesenhoff, Carolin Meyrl, Daniel Krause

|Jun 01, 2025
Deep learning-assisted analysis of biomarker changes after increase of dosing from aflibercept 2 mg to 8 mg in therapy-resistant neovascular age-related macular degeneration.

Michael Hafner, Ben Asani, Franziska Eckardt

|Feb 13, 2025
Internal Limiting Membrane Peeling in Primary Rhegmatogenous Retinal Detachment: Functional and Morphologic Results.

Franziska Eckardt, Julian Klaas, Jakob Siedlecki

|Sep 28, 2024
Corneal Epithelial Wavefront Error as a Novel Diagnostic Marker for Epithelial Basement Membrane Dystrophy.

Vitus Grauvogl, Wolfgang J Mayer, Jakob Siedlecki

Pageof 4

Frequent Collaborators

5 joint publications

Benedikt Schworm

4 joint publications

Wolfgang J Mayer

3 joint publications

Niklas Mohr

3 joint publications

Siegfried G Priglinger